View Future GrowthSyncona 過去の業績過去 基準チェック /06Synconaの収益は年間平均-24.8%の割合で減少していますが、 Capital Markets業界の収益は年間 減少しています。収益は年間5.9% 24.6%割合で 減少しています。主要情報-24.80%収益成長率-26.28%EPS成長率Capital Markets 業界の成長16.33%収益成長率-24.63%株主資本利益率-9.17%ネット・マージン139.30%前回の決算情報30 Sep 2025最近の業績更新お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025お知らせ • Jun 26Syncona Limited to Report Q1, 2025 Results on Aug 15, 2024Syncona Limited announced that they will report Q1, 2025 results on Aug 15, 2024お知らせ • Jun 21Syncona Limited to Report First Half, 2025 Results on Nov 14, 2024Syncona Limited announced that they will report first half, 2025 results on Nov 14, 2024お知らせ • Jan 05Syncona Limited to Report Q3, 2024 Results on Feb 08, 2024Syncona Limited announced that they will report Q3, 2024 results on Feb 08, 2024お知らせ • Nov 15Syncona Limited to Report Fiscal Year 2024 Results on Jun 20, 2024Syncona Limited announced that they will report fiscal year 2024 results on Jun 20, 2024すべての更新を表示Recent updatesお知らせ • Aug 08Syncona Limited Announces Board ChangesSyncona Limited announced, following its Annual General Meeting (AGM), Virginia Holmes has retired from the Board. Kemal Malik will take up the role of Senior Independent Director, effective immediately. He joined the Syncona Board in 2020, bringing 30 years of experience in global pharmaceutical research and development. In line with the Company's strategy update on 19 June 2025, in the event a new investment objective and policy, is approved by shareholders, the Company would expect to reduce the size of the Board for the new strategy.お知らせ • Jul 02Syncona Limited, Annual General Meeting, Aug 05, 2025Syncona Limited, Annual General Meeting, Aug 05, 2025.お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025お知らせ • Nov 19Syncona Limited Announces Step Down of Gian Piero Reverberi as Member of Its Board Audit CommitteeSyncona Limited announced the following board committee change: Following a review of board committee composition, Gian Piero Reverberi will step down as a member of the company's board audit committee with immediate effect.お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025お知らせ • Sep 20Syncona Limited Announces Appointment of John Roche as an Independent Non-Executive Director, Effective from 1 October 2024Syncona Limited announced the appointment of John Roche as an independent Non-Executive Director, with effect from 1 October 2024. John brings many years of broad financial experience to the role, having spent more than 15 years as a Partner at PricewaterhouseCoopers in Guernsey. During this time he served as managing partner of the Guernsey office for seven years and was leader of the Capital Markets Practice for twelve years. While at PwC, John specialised in providing audit and capital markets advisory services to listed investment companies and alternative asset management clients, developing extensive valuation experience. John is a Fellow of the Institute of Chartered Accountants in Ireland, who retired from practice in 2022. He is a Non-Executive Director and Chair of the Audit Committee of Riverstone Energy Limited, and a Guernsey resident. On appointment, John will join the Company's Audit Committee.お知らせ • Jul 05Syncona Limited, Annual General Meeting, Aug 06, 2024Syncona Limited, Annual General Meeting, Aug 06, 2024. Location: the offices of citco fund services, guernsey limited, frances house, sir william place, United Kingdomお知らせ • Jun 26Syncona Limited to Report Q1, 2025 Results on Aug 15, 2024Syncona Limited announced that they will report Q1, 2025 results on Aug 15, 2024お知らせ • Jun 21Syncona Limited to Report First Half, 2025 Results on Nov 14, 2024Syncona Limited announced that they will report first half, 2025 results on Nov 14, 2024お知らせ • Jan 05Syncona Limited to Report Q3, 2024 Results on Feb 08, 2024Syncona Limited announced that they will report Q3, 2024 results on Feb 08, 2024お知らせ • Nov 15Syncona Limited to Report Fiscal Year 2024 Results on Jun 20, 2024Syncona Limited announced that they will report fiscal year 2024 results on Jun 20, 2024お知らせ • Oct 19Syncona Seeks to Buy Remaining Shares of Freeline TherapeuticsSyncona Limited (LSE:SYNC) that its investment manager has submitted a proposal to buy the shares of Freeline Therapeutics Holdings plc (NasdaqCM:FRLN) that it doesn't already own, and plans to start talks with the company over a potential deal. The U.K. healthcare company said Wednesday that it is offering to pay $5.00 for each American Depositary Share of Freeline, a 20% premium over the volume weighted average price of $4.16 between Oct. 4 and Oct. 16. Syncona, which currently owns approximately 57.9% of Freeline, said there isn't a guarantee that any deal will be agreed. Syncona shares at 10:30 GMT were up 0.20 pence, or 0.2%, at 126.20 pence.お知らせ • Jun 29Syncona Limited to Report First Half, 2024 Results on Nov 16, 2023Syncona Limited announced that they will report first half, 2024 results on Nov 16, 2023お知らせ • Jun 28Syncona Limited, Annual General Meeting, Aug 01, 2023Syncona Limited, Annual General Meeting, Aug 01, 2023, at 09:30 Coordinated Universal Time. Location: Citco Fund Services (Guernsey) Limited, Frances House, Sir William Place, St Peter Port, Guernsey GY1 1GX Guernsey United Kingdom Agenda: To consider The Directors must lay the annual audited accounts for the financial year ended 31 March 2023 and the reports of the Directors and Auditors before the Shareholders and the Shareholders will be asked to receive and consider the financial statements and the reports; to consider Shareholders will be asked to confirm the reappointment of Deloitte LLP (Guernsey Branch) as Auditors until the conclusion of the next annual general meeting due to be held in 2024 and to grant authority to the Board to determine their remuneration; and to transact such other business matter.お知らせ • Dec 07Syncona Limited to Report Q3, 2023 Results on Feb 07, 2023Syncona Limited announced that they will report Q3, 2023 results on Feb 07, 2023収支内訳Syncona の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史LSE:SYNC 収益、費用、利益 ( )GBP Millions日付収益収益G+A経費研究開発費30 Sep 25-67-9423030 Jun 25-94-11820031 Mar 25-121-14318031 Dec 24-58-8018030 Sep 246-1819030 Jun 2418-721031 Mar 2431423031 Dec 23-57-8120030 Sep 23-144-16516030 Jun 23-92-11114031 Mar 23-40-5612031 Dec 22957812030 Sep 2223021213030 Jun 221241119031 Mar 221996031 Dec 21-92-1036030 Sep 21-203-2157030 Jun 21-62-8114031 Mar 21795321031 Dec 20714125030 Sep 20633029030 Jun 20-52-8326031 Mar 20-167-19624031 Dec 19-94-12021030 Sep 19-21-4419030 Jun 1920918421031 Mar 1943941124031 Dec 1842139322030 Sep 1840437421030 Jun 1830027318031 Mar 1819617315031 Dec 1720918912030 Sep 1722120610030 Jun 171531427031 Mar 1786774031 Dec 1664563030 Sep 1642352030 Jun 1623171031 Mar 165-11031 Dec 1521151030 Sep 1537311030 Jun 15464010質の高い収益: SYNCは現在利益が出ていません。利益率の向上: SYNCは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: SYNCは利益が出ておらず、過去 5 年間で損失は年間24.8%の割合で増加しています。成長の加速: SYNCの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: SYNCは利益が出ていないため、過去 1 年間の収益成長をCapital Markets業界 ( 14% ) と比較することは困難です。株主資本利益率高いROE: SYNCは現在利益が出ていないため、自己資本利益率 ( -9.17% ) はマイナスです。総資産利益率使用総資本利益率View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 07:51終値2026/05/22 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Syncona Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Kane SlutzkinDeutsche BankPaul CuddonDeutsche BankKenneth RumphJefferies LLC1 その他のアナリストを表示
お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025
お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025
お知らせ • Jun 26Syncona Limited to Report Q1, 2025 Results on Aug 15, 2024Syncona Limited announced that they will report Q1, 2025 results on Aug 15, 2024
お知らせ • Jun 21Syncona Limited to Report First Half, 2025 Results on Nov 14, 2024Syncona Limited announced that they will report first half, 2025 results on Nov 14, 2024
お知らせ • Jan 05Syncona Limited to Report Q3, 2024 Results on Feb 08, 2024Syncona Limited announced that they will report Q3, 2024 results on Feb 08, 2024
お知らせ • Nov 15Syncona Limited to Report Fiscal Year 2024 Results on Jun 20, 2024Syncona Limited announced that they will report fiscal year 2024 results on Jun 20, 2024
お知らせ • Aug 08Syncona Limited Announces Board ChangesSyncona Limited announced, following its Annual General Meeting (AGM), Virginia Holmes has retired from the Board. Kemal Malik will take up the role of Senior Independent Director, effective immediately. He joined the Syncona Board in 2020, bringing 30 years of experience in global pharmaceutical research and development. In line with the Company's strategy update on 19 June 2025, in the event a new investment objective and policy, is approved by shareholders, the Company would expect to reduce the size of the Board for the new strategy.
お知らせ • Jul 02Syncona Limited, Annual General Meeting, Aug 05, 2025Syncona Limited, Annual General Meeting, Aug 05, 2025.
お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025
お知らせ • Nov 19Syncona Limited Announces Step Down of Gian Piero Reverberi as Member of Its Board Audit CommitteeSyncona Limited announced the following board committee change: Following a review of board committee composition, Gian Piero Reverberi will step down as a member of the company's board audit committee with immediate effect.
お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025
お知らせ • Sep 20Syncona Limited Announces Appointment of John Roche as an Independent Non-Executive Director, Effective from 1 October 2024Syncona Limited announced the appointment of John Roche as an independent Non-Executive Director, with effect from 1 October 2024. John brings many years of broad financial experience to the role, having spent more than 15 years as a Partner at PricewaterhouseCoopers in Guernsey. During this time he served as managing partner of the Guernsey office for seven years and was leader of the Capital Markets Practice for twelve years. While at PwC, John specialised in providing audit and capital markets advisory services to listed investment companies and alternative asset management clients, developing extensive valuation experience. John is a Fellow of the Institute of Chartered Accountants in Ireland, who retired from practice in 2022. He is a Non-Executive Director and Chair of the Audit Committee of Riverstone Energy Limited, and a Guernsey resident. On appointment, John will join the Company's Audit Committee.
お知らせ • Jul 05Syncona Limited, Annual General Meeting, Aug 06, 2024Syncona Limited, Annual General Meeting, Aug 06, 2024. Location: the offices of citco fund services, guernsey limited, frances house, sir william place, United Kingdom
お知らせ • Jun 26Syncona Limited to Report Q1, 2025 Results on Aug 15, 2024Syncona Limited announced that they will report Q1, 2025 results on Aug 15, 2024
お知らせ • Jun 21Syncona Limited to Report First Half, 2025 Results on Nov 14, 2024Syncona Limited announced that they will report first half, 2025 results on Nov 14, 2024
お知らせ • Jan 05Syncona Limited to Report Q3, 2024 Results on Feb 08, 2024Syncona Limited announced that they will report Q3, 2024 results on Feb 08, 2024
お知らせ • Nov 15Syncona Limited to Report Fiscal Year 2024 Results on Jun 20, 2024Syncona Limited announced that they will report fiscal year 2024 results on Jun 20, 2024
お知らせ • Oct 19Syncona Seeks to Buy Remaining Shares of Freeline TherapeuticsSyncona Limited (LSE:SYNC) that its investment manager has submitted a proposal to buy the shares of Freeline Therapeutics Holdings plc (NasdaqCM:FRLN) that it doesn't already own, and plans to start talks with the company over a potential deal. The U.K. healthcare company said Wednesday that it is offering to pay $5.00 for each American Depositary Share of Freeline, a 20% premium over the volume weighted average price of $4.16 between Oct. 4 and Oct. 16. Syncona, which currently owns approximately 57.9% of Freeline, said there isn't a guarantee that any deal will be agreed. Syncona shares at 10:30 GMT were up 0.20 pence, or 0.2%, at 126.20 pence.
お知らせ • Jun 29Syncona Limited to Report First Half, 2024 Results on Nov 16, 2023Syncona Limited announced that they will report first half, 2024 results on Nov 16, 2023
お知らせ • Jun 28Syncona Limited, Annual General Meeting, Aug 01, 2023Syncona Limited, Annual General Meeting, Aug 01, 2023, at 09:30 Coordinated Universal Time. Location: Citco Fund Services (Guernsey) Limited, Frances House, Sir William Place, St Peter Port, Guernsey GY1 1GX Guernsey United Kingdom Agenda: To consider The Directors must lay the annual audited accounts for the financial year ended 31 March 2023 and the reports of the Directors and Auditors before the Shareholders and the Shareholders will be asked to receive and consider the financial statements and the reports; to consider Shareholders will be asked to confirm the reappointment of Deloitte LLP (Guernsey Branch) as Auditors until the conclusion of the next annual general meeting due to be held in 2024 and to grant authority to the Board to determine their remuneration; and to transact such other business matter.
お知らせ • Dec 07Syncona Limited to Report Q3, 2023 Results on Feb 07, 2023Syncona Limited announced that they will report Q3, 2023 results on Feb 07, 2023